Tvardi Therapeutics (TVRD) Share-based Compensation (2013 - 2026)
Tvardi Therapeutics (TVRD) recorded Share-based Compensation of $335,000 in Q2 2026, down 46.6% from $627,000 a year earlier and down 9.5% from the prior quarter.
Powered by 
Analysis
Tvardi Therapeutics (TVRD) Share-based Compensation (2013 - 2026) Analysis & Trends
On a TTM basis, Tvardi Therapeutics' Share-based Compensation came in at $1.4 million as of Jun 30, 2026, up 61.3% year-over-year; for FY2025, it came in at $1.4 million, up 338.6% from FY2024.
- Annual Share-based Compensation has a five-year compound annual growth rate of -37.6% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $319,000 in FY2024 (-97.7%), $13.73 million in FY2023 (-22.6%), $17.73 million in FY2022 (-14.7%) and $20.79 million in FY2021 (+40.1%).
- The Q2 2026 figure is the lowest quarterly Share-based Compensation since Q1 2025.
- On a year-over-year basis, Share-based Compensation rose in three of the last seven quarters, with growth averaging 99.1%.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 362.5% in Q1 2026, against a decline of 97.8% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $370,000 (Q1 2026), $353,000 (Q4 2025) and $339,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Tvardi Therapeutics | 12.48 Mn | 12.48 Mn | - | 335,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 335,000.00 |
| Mar 31, 2026 | 370,000.00 |
| Dec 31, 2025 | 353,000.00 |
| Sep 30, 2025 | 339,000.00 |
| Jun 30, 2025 | 627,000.00 |
| Mar 31, 2025 | 80,000.00 |
| Dec 31, 2024 | 79,000.00 |
| Sep 30, 2024 | 80,000.00 |
| Jun 30, 2024 | -3.19 Mn |
| Mar 31, 2024 | 3.35 Mn |
| Dec 31, 2023 | 3.60 Mn |
| Sep 30, 2023 | 3.33 Mn |
| Jun 30, 2023 | 3.44 Mn |
| Mar 31, 2023 | 3.35 Mn |
| Dec 31, 2022 | 3.80 Mn |
| Sep 30, 2022 | 3.57 Mn |
| Jun 30, 2022 | 4.66 Mn |
| Mar 31, 2022 | 5.70 Mn |
| Dec 31, 2021 | 8.78 Mn |
| Sep 30, 2021 | 4.39 Mn |
API Access
Tvardi Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TVRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();